Fixed-scope project
For one high-impact deliverable. A lean IEP, an RWE landscape, a target product profile or a trial design, scoped and delivered to a fixed timeline.
✓ Fixed price, agreed upfront
✓ Defined scope and timeline
✓ No change orders
Fixed scope, fixed price, agreed upfront. Outcomes-based engagements with no change orders, no surprises and no padded hours.

By aligning our incentives to your programme outcomes, we can guarantee:
We believe in the highest-quality outcomes, and change orders fundamentally contradict quality delivery.
Surprises are best left for birthday parties. Your price is agreed before we start.
The drug development landscape is dynamic, and so are we, adapting as it shifts without change orders.
Decades of experience embedded in your team across clinical development, RWE, engineering, AI and project management.
Incomplete deliveries are deemed unacceptable in every other industry. Why should you accept them here?
We understand the downstream cost of missed deadlines, so timely delivery is a key metric and a point of pride.
Every engagement is priced to the outcome, agreed upfront, with no change orders. Pick the shape that fits where your programme is.
For one high-impact deliverable. A lean IEP, an RWE landscape, a target product profile or a trial design, scoped and delivered to a fixed timeline.
✓ Fixed price, agreed upfront
✓ Defined scope and timeline
✓ No change orders
For an end-to-end development programme. Senior expertise embedded in your team across clinical development, trial design, evidence generation and regulatory strategy.
✓ Priced to milestones and outcomes
✓ Continuous, adaptable support
✓ Our platforms included
For ongoing or urgent needs. Retained access to our team and platforms, or a rapid rescue when a programme is off track.
✓ Flexible retainer or rapid start
✓ Fast diagnosis and a clear plan
✓ No change orders
World-class drug development expertise supported by technology platforms that actually work.
Inovia's seasoned drug development team excels at guiding assets through approval, while pioneering strategies tailored to each biotech's unique pipeline for agility and success.
Leverage our proprietary platforms, InoviaIEP, InovaLandscape, RWE360 and InovaMine, to deliver regulatory-grade outcomes in minutes, not months, and outpace every CRO.
Trusted by global biotechs, our track record spans multiple development stages and dozens of clinical programmes, delivering measurable results that accelerate milestones.

Every month a programme slips has a price: burn, lost exclusivity and competitors closing the gap. Our Cost of Delay Index puts a number on that month, so you can weigh it against the cost of moving faster.
✓ Benchmark the monthly cost of delay by phase
✓ Burn, lost exclusivity and competitor lead, quantified
✓ The numbers to justify paying for speed and outcomes
Tell us where your programme is and what you need to prove. We will come back with a defined scope, timeline and price, with no change orders.